Gout caused by lead toxicity, assigned when the affected joint or anatomical site is not documented or cannot be specified.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- General
Documentation tips
What should appear in the chart to support M10.10.
Source · Editorial brief grounded in 6 cited references ↓
- Record the confirmed or suspected lead exposure source (occupational, environmental, ingestion) and reference any blood lead level result to support the toxic etiology.
- Identify the affected joint by name whenever possible — switching from M10.10 to a site-specific M10.1x code improves specificity and reduces audit risk.
- Append T56.0- (toxic effects of lead and its compounds) as an additional code per ICD-10-CM tabular instruction for M10.1 codes.
- Distinguish acute flare from chronic gouty arthropathy in the note; if chronic with or without tophi, the M1A.1- subcategory applies rather than M10.10.
- Document serum uric acid levels, synovial fluid analysis results, and any imaging showing joint changes to substantiate the gout diagnosis.
Related CPT procedures
Procedure codes commonly billed with M10.10. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M10.10 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Skipping the required companion code T56.0-: M10.10 requires a 'Use Additional' code for toxic effects of lead — omitting it is a known audit flag.
- Using M10.10 when the joint is documented: if the provider names even one joint, a site-specific M10.11–M10.19 code is required and M10.10 becomes incorrect.
- Confusing lead-induced gout with drug-induced gout (M10.2-) or renal impairment gout (M10.3-): the etiology must be explicitly attributed to lead in the documentation before assigning M10.10.
- Defaulting to M10.9 (gout, unspecified) when the cause is documented as lead: M10.9 is appropriate only when etiology is unknown, not when lead exposure is identified.
- Billing M10.1 (parent code) instead of M10.10: M10.1 is non-billable; M10.10 is the billable specificity level when site is unspecified.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
M10.10 is the fallback code within the M10.1 (lead-induced gout) subcategory when the provider has documented a causal link to lead exposure but has not identified a specific joint. Lead-induced gout arises from chronic lead toxicity impairing renal uric acid excretion, driving hyperuricemia and subsequent crystal deposition. Because the mechanism is toxic rather than idiopathic or drug-related, it requires a different parent code than M10.0 (idiopathic) or M10.2 (drug-induced).
When a specific joint is named in the note — shoulder, elbow, wrist, hand, hip, knee, ankle/foot, or vertebrae — move to the appropriate site-specific code under M10.1 (e.g., M10.161 for right knee, M10.162 for left knee). Reserve M10.10 only when the documentation genuinely lacks a joint location. Per ICD-10-CM Tabular List instruction, also code the toxic effect of lead using T56.0- to capture the underlying exposure.
This code sits in Chapter 13 (M00–M99, Diseases of the Musculoskeletal System and Connective Tissue) and is fully billable as of FY2026 (effective October 1, 2025). It covers acute gout attacks, gout flares, and podagra when the etiology is lead and the site is unspecified. If the condition has become chronic with or without tophi, consider the M1A.1- category instead.
Sibling codes
Other billable codes under M10.1 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01When is M10.10 the correct code versus a site-specific M10.1x code?
02Is a companion code required with M10.10?
03How does M10.10 differ from M10.9 (gout, unspecified)?
04Should chronic lead-induced gout still be coded M10.10?
05Can M10.10 be used for an acute gout flare in a patient with known prior lead exposure?
06What distinguishes lead-induced gout (M10.1-) from drug-induced gout (M10.2-)?
07Does M10.10 require laterality?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (FY2026, effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M10-/M10.10
- 03icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M10-/M10
- 04aapc.comhttps://www.aapc.com/codes/icd-10-codes/M10.10
- 05outsourcestrategies.comhttps://www.outsourcestrategies.com/blog/documenting-gout-symptoms-diagnosis-and-icd-10-codes/
- 06precisionhub.comhttps://precisionhub.com/types-of-gout-icd-10-codes-complete-guide-for-accurate-diagnosis/
Mira AI Scribe
Mira AI Scribe captures lead exposure history (occupational, environmental, or ingestion source), blood lead level if ordered, the joint or body region involved in the current flare, serum uric acid value, and any prior gout episodes. That documentation drives selection between M10.10 (site unspecified) and the site-specific M10.1x codes, and supports the required companion T56.0- toxic-effect code — preventing a downcode to M10.9 or a claim rejection for missing etiology linkage.
See how Mira captures M10.10 documentation